Consonance Capital Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Consonance Capital Management’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,240,709	Closed	-$23.3M	–	30
2015 Q4	$23.3M	Buy	2,240,709 +205,000	+10%	+$2.78M	3.12%	11
2015 Q3	$37.6M	Buy	2,035,709 +859,514	+73%	+$16.6M	5.29%	8
2015 Q2	$22.9M	Sell	1,176,195 -22,141	-2%	-$392K	2.3%	13
2015 Q1	$21.1M	Sell	1,198,336 -476,225	-28%	-$8M	1.92%	16
2014 Q4	$26.8M	Buy	1,674,561 +95,000	+6%	+$1.27M	3.45%	13
2014 Q3	$19.9M	Sell	1,579,561 -390,500	-20%	-$5.57M	2.73%	15
2014 Q2	$30.8M	Sell	1,970,061 -84,963	-4%	-$1.25M	4.58%	11
2014 Q1	$27M	Buy	2,055,024 +1,079,008	+111%	+$16.9M	4.01%	12
2013 Q4	$15.7M	Buy	+976,016	New	+$15.6M	2.57%	18

Other funds holding OSIR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Consonance Capital Management's OSIR Position: Q1 2016 in Review

Consonance Capital Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2016, closing a stake of 2,240,709 shares — an estimated $23.3M sold.

Consonance Capital Management first reported a position in OSIR in Q4 2013 and held it in 9 quarters. The position peaked at $37.6M in Q3 2015. 80 funds tracked by Wall St. Rank hold OSIR as of Q1 2016.

Consonance Capital Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
Consonance Capital Management sold 2,240,709 Osiris Therapeutics, Inc. Common Stock shares in Q1 2016, an estimated $23.3M.
Consonance Capital Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2013 and held it in 9 quarters.
Consonance Capital Management's Osiris Therapeutics, Inc. Common Stock position peaked at $37.6M in Q3 2015.
80 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2016.

Based on Consonance Capital Management's 13F filing for Q1 2016, filed 16 May 2016.